Abstract
This observational study evaluated a modified immunoprophylactic regimen (hepatitis B immune globulin [HBIG]) and a dose of thimerosal-free monovalent hepatitis B (HB) vaccine shortly after birth followed by doses of thimerosal-free bivalent Haemophilus influenzae type b (Hib)-HB vaccine at 2 and 4 months of age, and a booster at 12 months of age) in infants at high risk of hepatitis B virus (HBV) infection (mothers HBeAg+).
Original language | English |
---|---|
Pages (from-to) | 777 - 781 |
Number of pages | 5 |
Journal | The Pediatric Infectious Disease Journal |
Volume | 28 |
Issue number | 9 |
DOIs | |
Publication status | Published - 2009 |